Evidence map›Paper›PMID 32546814›Full record

ArticleScientific reports2020

Ergot alkaloid mycotoxins: physiological effects, metabolism and distribution of the residual toxin in mice.

Priyanka Reddy, Joanne Hemsworth, Kathryn M Guthridge, Antony Vinh, Simone Vassiliadis, Vilnis Ezernieks, German C Spangenberg, Simone J Rochfort

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Rye (Frontiers in nutrition · 2025
    Review
  5. Article
  6. Review
  7. Risks for animal health related to the presence of ergot alkaloids in feed.EFSA journal. European Food Safety Authority · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. A Metabolomic Study ofMetabolites · 2022
    Article
  12. Metabolic Potential ofMicroorganisms · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Priyanka ReddyAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia. priyanka.reddy@agriculture.vic.gov.au.
Joanne HemsworthAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Kathryn M GuthridgeAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Antony VinhSchool of Life Sciences, La Trobe University, Bundoora, Victoria, 3083, Australia.
Simone VassiliadisAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Vilnis EzernieksAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
German C SpangenbergAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
Simone J RochfortAgriculture Victoria, AgriBio, Centre for AgriBioscience, Bundoora, Victoria, 3083, Australia.
AgriBio · AUAgriculture Victoria · AULa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complex ergot alkaloids, ergovaline and ergotamine, cause dysregulation of physiological functions, characterised by vasoconstriction as well as thermoregulatory and cardiovascular effects in grazing livestock. To assess the effect of the mycotoxins, blood pressure and heart rate of male mice were measured, and metabolite profiling undertaken to determine relative abundances of both ergotamine and its metabolic products in body and brain tissue. Ergotamine showed similar cardiovascular effects to ergovaline, causing elevations in blood pressure and reduced heart rate. Bradycardia was preserved at low-levels of ergovaline despite no changes in blood pressure. Ergotamine was identified in kidney, liver and brainstem but not in other regions of the brain, which indicates region-specific effects of the toxin. The structural configuration of two biotransformation products of ergotamine were determined and identified in the liver and kidney, but not the brain. Thus, the dysregulation in respiratory, thermoregulatory, cardiac and vasomotor function, evoked by ergot alkaloids in animals observed in various studies, could be partially explained by dysfunction in the autonomic nervous system, located in the brainstem.

Indexed as

Animal FeedAnimalsBlood PressureErgot AlkaloidsErgotamineErgotaminesMaleMiceMice, Inbred C57BLMycotoxinsToxins, BiologicalVasoconstrictionErgot AlkaloidsErgotamineErgotaminesergovalineMycotoxinsToxins, Biological

Identifiers

PMID32546814
PMCPMC7298049
OpenAlexW3035445729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.